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Abstract  
 
Introduction: Post-stroke fatigue (PSF) is common and is one of the most distressing symptoms after 
stroke. It has a negative impact on physical, social and psychological functioning: it is also associated 
with poor outcomes and increased mortality. The effective management of PSF is therefore 
regarded as a clinical priority.   
 
Method: Mixed-methods design with three overlapping phases. Phase 1 will be a survey of existing 
fatigue management within the UK. In phase 2, interviews and focus groups will be conducted with 
stroke survivors with fatigue, carers and clinicians to determine strategies used to manage fatigue 
successfully. In phase 3, data from phases 1 and 2 will contribute to the co-design of a fatigue 
management programme with the NotFAST2 study Patient and Public Involvement group. This will 
be further refined through subsequent focus groups which will include those with fatigue associated 
with other health conditions. 
 
Results: Survey data will be analysed using descriptive statistics. Interview and focus group data will 
be analysed using a framework approach. 
 
Conclusion: PSF requires a comprehensive management programme necessitating input from key 
stakeholders. A PSF programme will be developed which will be tested in a future randomised 
controlled trial.  
 
 
Keywords:  
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Introduction 
Post-stroke fatigue (PSF) is an ‘overwhelming feeling of exhaustion or tiredness’, which is not related 
to exertion, and which does not typically improve with rest (De Groot et al, 2003). PSF is common, 
and affects 50% of people after their stroke (Cumming et al, 2016; Hinkle et al, 2017).  It is 
distressing for the stroke survivor (Van der Werf et al, 2001), linked to poor outcome such as 
disability, depression and lower quality of life (Lerdal and Gay, 2017), increased mortality (Glader et 
al, 2002), and contributes to significant carer burden (Mandiliya et al, 2016).  PSF can occur in those 
who have made an otherwise good recovery and can occur early after stroke, or later (Hawkins et al, 
2017) and can affect all aspects of daily life (Worthington et al, 2017). However, the effect of fatigue 
is most likely to be noticed when people are discharged from hospital and are back in their own 
homes. The management of PSF is recognised as an ongoing national and international research 
priority (Norrving et al, 2018). 
 
Although researchers have endeavoured to explain PSF mechanisms (De Doncker et al, 2018), these 
remain unclear. This may be due, in part, to the lack of a single, accepted and widely adopted 
definition of post-stroke fatigue (Barker-Collo et al, 2007: Thomas et al, 2019) and also because of 
misunderstanding around the use of  key  terms such as fatigue and tiredness (Thomas et al, 2019).  
It is known that there are many contributing factors (Mandiliya et al, 2016; Cumming et al, 2016; Aali 
et al 2020) and it would seem that each research team previously has concentrated on specific 
issues: exercise, sleep, nutrition, medication and psychological interventions.  In an attempt to 
evaluate the overall evidence, several comprehensive reviews (Hinkle et al, 2017; Aali et al, 2020) 
and Cochrane systematic reviews (Kennedy and Kidd, 2018; Wu et al 2015) have compared findings 
from randomised controlled trials (RCTs) and clinical studies of PSF to draw overarching conclusions.  
All the reviews to date have concluded that there is insufficient evidence of the efficacy of the tested 
interventions in trials, and that more robust research with adequate sample sizes is required. For 
example, in the review conducted by Wu et al (2015) the authors reported a pooled SMD of -1.07 
(95% confidence interval (CI) -1.93 to -0.21) in favour of reducing fatigue with interventions in the 
studies they included. However, this benefit was not found when data from the more rigorous 
studies were examined: SMD -0.38 (95% CI -0.80 to 0.04) with adequate allocation concealment and 
SMD -1.10 (95% CI -2.31 to 0.11) with appropriate blinding of assessors.  The results from the studies 
and reviews demonstrate the need for more research into PSF and underline the need for this 
research to be more robust and better designed. 
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Consequently, current clinical practice guidelines rely on low levels of evidence, such as expert 
consensus, to make recommendations for PSF. There are therefore few specific recommendations in 
UK (Royal College of Physicians, 2016) or other international clinical guidelines (e.g. Australian 
National Stroke Foundation, 2010) for its management.  Broadly, international expert consensus 
supports assessment and information provision, the provision of rehabilitation during periods of 
lower fatigue, pacing of activity, exercise and advice on sleep (Lanctot et al, 2019). It is suggested 
this improves outcome and quality of life of stroke survivors as well as reducing caregiver burden.  
 
In the absence of definitive guidance, and with an incomplete evidence base, our aim is to conduct a 
study to develop a fatigue management programme for stroke survivors with PSF. We will not 
concentrate on one aspect of management but instead will take a comprehensive but pragmatic 
view and collect data from experts: stroke survivors, carers (that is, unpaid carers who are likely to 
be family or friends) and clinicians. We will collect data on both PSF strategies and on approaches 
used in fatigue management more broadly. We have conducted a comprehensive scoping review 
(Aali et al, 2020) on PSF to inform our research proposal. The specific objectives are to: 
 
•  understand and document existing key management practices for PSF.  
• gain insights from the experiences and expertise of those who have fatigue, those who have 
had help to manage it or those who offer support.  
• Utilise findings to co-design a community post-stroke fatigue management intervention.  
 
We envisage that the proposed programme could be evaluated in a future, appropriately powered 
randomised controlled trial.  
 
Methods 
 
Ethics. 
Ethical approval was granted by University of Nottingham, Faculty of Medicine and Health Sciences 
Research Ethics Committee (Reference 480-2001, 10 March 2020). 
 
Design 
This is a mixed-methods study, with three overlapping phases.  
 
Phase 1: Survey.  
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We will conduct a survey of fatigue management provision within the UK. We will particularly focus 
on stroke but will collect relevant data on other conditions where fatigue is a key symptom (for 
example, multiple sclerosis, rheumatoid arthritis). We will examine eligibility criteria for referral to a 
health professional or a service for fatigue management and examine the format and content of 
interventions currently available. We will collect data on whether fatigue assessments are routinely 
used, whether there is any routine follow-up provided and whether there are any differences in 
management for post-stroke fatigue as compared to fatigue management in other conditions. 
 
Data will be collected by contacting allied health professionals (AHPs), psychologists, doctors and 
nurses through professional networks, Special Interest Groups and via social media. We will ask 
colleagues to forward details of the survey to others with an interest in fatigue (snowballing 
method). The research team will also use professional contacts to alert clinicians to the survey.  
Participants will be eligible if they are clinicians from hospital or community fatigue services or who 
have an interest/expertise in fatigue management in PSF or in other long-term conditions. The 
survey will be available to complete online or can be returned by post. The aim will be to obtain as 
many responses as possible over a three-month period. 
 
Phase 2: Interviews and focus groups.  
Interviews and focus groups will be conducted with stroke survivors with fatigue, carers and 
clinicians about their experiences and strategies used to successfully manage fatigue. We will use 
both face to face interview and focus groups because both formats have been found to 
provide different and enriched data (Lambert and Loiselle 2008) and also provide participants 
with choice. Participants will either participate in focus groups or semi structured interviews. 
 
For stroke survivors and carers, we intend to use a multi-pronged approach to advertising the 
study: locally and regionally -posters and flyers in the community and in GP surgeries, 
community hospitals, stroke units and outpatient departments, local stroke clubs, community 
centres and through existing national UK impatient networks (such as stroke lay conferences) 
and through social media. A maximum variation sampling strategy (Palinkas et al, 2015) will be 
used to ensure we capture a broad range of experiences such as age, gender, time since 
stroke, ethnicity and geographical location. We want to be as inclusive as possible, and we will 
therefore include people with aphasia. 
Interviews and focus group discussions, based on participant preference, will be conducted with 
stroke survivors with fatigue, carers and clinicians. We expect to achieve data adequacy (based on 
8 
 
similar previous studies) by conducting interviews with up to twenty stroke survivors with fatigue, 
ten carers and 20 clinicians. However, our sample size will ultimately be guided by achieving data 
saturation. Two focus groups with six to eight participants in each will be conducted. Participants will 
be eligible if they are willing to give written informed consent and meet the following study criteria: 
• Stroke survivors - have a diagnosis of stroke, are aged 18 years or over and have (or have 
had) self-defined PSF. They will be excluded if they have a previous significant history of 
fatigue before stroke- as defined by themselves.  
• Carers- lives with and provides care (physical or psychological) for a stroke survivor with 
fatigue and is 18 years or over. These are non-paid carers who are likely to be family 
members or friends.  
• Clinicians- are a registered nurse, doctor, psychologist or AHP, working in a service providing 
fatigue management and/or have a recognised interest/expertise in fatigue management 
broadly and/or in post stroke fatigue specifically. We will include international experts 
where possible for the interviews. 
All interviews and focus groups will be semi-structured, and will use interview and focus group topic 
guides with key issues relating to fatigue informed by our recent, wide ranging review of the 
relevant literature (Aali et al, 2020). The interviews will be conducted remotely via (Skype/video 
conference/telephone) or face-to-face, depending on location, time availability and preferences of 
participants and the research team. Focus groups will be held in an easily accessible location such as 
on university premises or using virtual groups using telephone or video conferencing.  In order to 
keep an accurate record, all interviews and focus groups will be audio recorded, transcribed 
verbatim and anonymized.  The research team will also produce a contemporary field note after 
completion of each interview and focus group.  
 
For stroke survivors and carers our focus will be to collect data on: individual experiences of having 
fatigue; history and onset of fatigue; characteristics of the fatigue; what helped and what made it 
worse; and exploring any professional support and, or, information and whether it was useful or 
not.  We are also keen to determine what, in the participants’ opinions should constitute best 
practice for addressing PSF in the absence of clinical recommendations.  In any instance where we 
have a survivor-carer dyad, we will not have both in the same group: previous experiences have 
suggested this may prevent individuals from speaking freely.   
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We will also interview 20 clinicians with an interest or recognised expertise in fatigue. We have 
opted largely for interviews for this group because it may be difficult to bring clinicians together 
for focus groups. However, we will endeavour to do this as well. We also want to include those 
with expertise in fatigue-related other conditions (such as MS) and international experts. We 
will recruit via targeted personal emails and will aim to get a balance of different professionals, 
different condition expertise and national and international views. For professionals, our focus 
will be to collect data on whether participants work as part of a fatigue service or not; their thoughts 
and experiences of specific advice and interventions and their use of the fatigue research evidence.  
 
Phase 3: Development of fatigue management programme. 
In this phase, data and findings from key research literature (specifically from the most recent 
reviews, that is, Aali et al, 2020; Hinkle et al, 2017) and from phases 1 and 2 of the study, will help 
guide priority setting in the co-design of a new fatigue management programme. We will determine 
what should constitute best practice for addressing PSF in the absence of research based clinical 
recommendations in terms of the programme content, programme format, overall design and 
presentation. Our co-design is informed by an Experience-based Co-design (EBCD) methodology 
utlising the findings from earlier phases to trigger ideas and solutions for the new fatigue 
management programme, and inform individual and joint priority setting (King’s Fund, 2018).  Ideas 
on preliminary content and delivery will be explored through focus groups with stroke survivors, 
carers, people with fatigue from other conditions and clinicians and further refined through staged 
discussions with the study Patient and Public Involvement (PPI) group. 
 
Using a co-design approach, we will aim to take an equitable approach to priority setting and 
intervention design aiming for a balance and ratio of professionals, stroke survivors and carers.  We 
will also include those with experience of fatigue from other health conditions (e.g. multiple sclerosis, 
rheumatoid arthritis) where the literature suggests the features of the presenting fatigue are similar 
to those in stroke or where services seem to be addressing similar symptoms. We will be flexible, 
depending on the data collected, as to how the groups are configured. We may also recruit some 
number of participants from phase 2 to take part in these focus groups. These participants would be 
selected on the basis that they had key experiences or novel ideas around fatigue management. The 
overall aim is that the participants will have the opportunity to shape the programme and consider 
how it might be best delivered. 
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Informed consent 
In phase 1, completion and return of the questionnaires (either online or by post) will imply 
informed consent to participate. Each questionnaire will have a front-page detailing information 
about the study and contact details for obtaining further information. A separate information sheet 
will also be provided.    
  
In phases 2 and 3 all participants will provide informed consent. The researcher will explain the 
details of the study and provide a participant information sheet, ensuring that the participant 
has sufficient time to consider participating or not.  The researcher will answer any questions that 
the participant has concerning study participation.  
 
No personal information will be collected until participants have given their consent.  For patients 
who are physically unable to sign the consent form (e.g. weakness in dominant hand due to stroke) 
then consent will be given using a mark or line in the presence of an independent witness (who has 
no involvement in the study) who will then corroborate by signing the consent form.   
  
An accessible information sheet will be provided to those with aphasia. This follows standard 
aphasia-friendly principles with one idea presented per page in short simple sentences in large font. 
Key words are emboldened and each idea is represented by a pictorial image to support 
understanding of what the study is about. The researcher will be trained to support understanding 
further by reading parts of the information aloud and using supportive gestures/actions. Participants 
who have used the accessible information provision will be provided with an aphasia-friendly 
consent form and asked to initial all boxes before signing.  
 
Analysis 
Data from the survey will be analysed using SPSS and Excel using descriptive statistics. Free text data 
will be analysed using broad categories and used to illustrate the quantitative data. 
 
Qualitative interview and focus group data will be analysed separately, managed using NVivo 
software, and use a framework approach (Gale, 2013). A working analytical framework will be 
developed simultaneously and iteratively with the coding stage, and data chunks will be transferred 
onto a framework matrix, which will also be informed by theory.  
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Study Management 
The chief investigator will have overall responsibility for study management and will oversee all 
study management. A study steering group, comprising the co-investigators and PPI members will 
oversee the study.  
 
Discussion  
 
PSF can have significant consequences for stroke survivors and their recovery: it is not simply a 
trivial, unimportant symptom. Despite recognition of the need to manage PSF appropriately, it is 
accepted that the current evidence base around PSF and its management is weak which may be 
because previous research has examined potential individual contributing factors rather than 
focusing on the broader issues. However, given the complex, multi-factorial profile of PSF, a single 
therapy approach for the management of PSF is unlikely to be appropriate. We therefore have 
suggested that, given PSF is multi-faceted, it requires a comprehensive management programme. 
Involving experts (that is, stroke survivors, carers, people with fatigue arising from other conditions 
and clinicians working with those with PSF and with fatigue from other conditions) in the co-design 
of such a programme is vital as they can share the strategies which they believe are successful, from 
a concrete and informed perspective.  
 
Using experts, that is, both patient and professional experts, in the programme development also 
has additional benefits. Aside from offering legitimacy to the programme, including a range of 
participants and a mixed methods design ensures that evidence is collected from several sources 
and that key issues are triangulated. Moreover, having a programme that is co-designed provides 
the best opportunity to develop a programme that is practicable, accessible, which people will 
engage with and which can be sustained over the longer term. Such a programme also has the 
added benefit that, in drawing on the experiences of experts, there is the potential to enable stroke 
survivors to self-manage their own fatigue. If individuals have belief in their capability (self-efficacy) 
to manage their own condition, this can have positive impacts.  
 
The research is novel given the fact that it uses key stakeholders in the development of the 
programme. It also uses a mixed methods design which incorporates survey, interview, focus group 
and co-design methodologies in order to be able to draw data and findings together from a range of 
credible sources. It also draws on both knowledge of PSF techniques as well as from non-stroke 
fatigue sources. However, as with any proposed research study, there could be difficulties in 
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conducting the study. It is possible that there is not a satisfactory response to the survey which 
would have implications for the generalisability of our results. It is also possible that the required 
numbers of participants in the second phase are not achieved, or that we are not successful in 
including a diverse range of participants. Both of these would limit the value of our results.  
 
It is our intention that this research will lay the foundations for conducting a future definitive RCT to 
test the efficacy of the programme and to determine whether stroke survivors could indeed self-
manage their fatigue. If management of PSF were possible, it would potentially reduce its impact 
and the concomitant effects on recovery and quality of life. Although our proposed RCT will be 
conducted in the UK, the results would be relevant worldwide as the issue of managing post-stroke 
fatigue appropriately is a global issue, as reflected in current national and international clinical 
guidelines and on the fatigue literature. 
 
Key findings 
 
• We will identify successful strategies to be used in developing a comprehensive fatigue 
management programme  
• This programme will need to be fully evaluated in future studies and trials. 
 
What the study has added  
 
This protocol details proposed research to develop a comprehensive programme to manage post-
stroke fatigue (PSF) using expert input from key stakeholders to shape the proposed intervention.  
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